glp-1 launch NEW FOR 2026: Medicare Bridge Program Access to eligible weight-loss medications for approximately $50/month* *Eligibility and physician approval required. Starting July 1, 2026, Medicare will a new temporary program called NDSU, Sanford Health launch study

Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2

We invite you to discuss the potential of GLP-1 medications and explore how they can be integrated into your personalized diabetes management plan

Studies have shown that about 25% of the weight loss that occurs from dieting is lean body mass [4] and that rapid weight loss, like what occurs with GLP1s, is associated with more loss of lean body mass than those who achieve a slower weight loss

Eating smaller, more frequent meals can reduce nausea and bloating

What are the main side effects observed in Retatrutide research

But Williams ad isnt by a pharma